pWZL Blast mouse E-cadherin Citations (11)

Originally described in: Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways.
Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA Cancer Res. 2008 May 15. 68(10):3645-54. PubMed Journal

---

Articles Citing pWZL Blast mouse E-cadherin

Articles
Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor formation. Cellurale C, Sabio G, Kennedy NJ, Das M, Barlow M, Sandy P, Jacks T, Davis RJ. Mol Cell Biol. 2011 Apr;31(7):1565-76. doi: 10.1128/MCB.01122-10. Epub 2011 Jan 31. PubMed
The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti AR, Poletti A, Daidone MG, Dupont S, Basso G, Bicciato S, Piccolo S. Cell. 2011 Nov 11;147(4):759-72. doi: 10.1016/j.cell.2011.09.048. PubMed
miR-200b restoration and DNA methyltransferase inhibitor block lung metastasis of mesenchymal-phenotype hepatocellular carcinoma. Ding W, Dang H, You H, Steinway S, Takahashi Y, Wang HG, Liao J, Stiles B, Albert R, Rountree CB. Oncogenesis. 2012 Jun 11;1:e15. doi: 10.1038/oncsis.2012.15. PubMed
Mammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherin. Manuel Iglesias J, Beloqui I, Garcia-Garcia F, Leis O, Vazquez-Martin A, Eguiara A, Cufi S, Pavon A, Menendez JA, Dopazo J, Martin AG. PLoS One. 2013 Oct 4;8(10):e77281. doi: 10.1371/journal.pone.0077281. eCollection 2013. PubMed
EFA6B antagonizes breast cancer. Zangari J, Partisani M, Bertucci F, Milanini J, Bidaut G, Berruyer-Pouyet C, Finetti P, Long E, Brau F, Cabaud O, Chetaille B, Birnbaum D, Lopez M, Hofman P, Franco M, Luton F. Cancer Res. 2014 Oct 1;74(19):5493-506. doi: 10.1158/0008-5472.CAN-14-0298. Epub 2014 Aug 12. PubMed
E-Cadherin Facilitates Protein Kinase D1 Activation and Subcellular Localization. Li Z, Zhang C, Chen L, Li G, Qu L, Balaji KC, Du C. J Cell Physiol. 2016 Mar 17. doi: 10.1002/jcp.25382. PubMed
E-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells. Palen K, Weber J, Dwinell MB, Johnson BD, Ramchandran R, Gershan JA. Oncotarget. 2016 Jul 12;7(28):43363-43375. doi: 10.18632/oncotarget.9715. PubMed
Loss of E-cadherin provides tolerance to centrosome amplification in epithelial cancer cells. Rhys AD, Monteiro P, Smith C, Vaghela M, Arnandis T, Kato T, Leitinger B, Sahai E, McAinsh A, Charras G, Godinho SA. J Cell Biol. 2018 Jan 2;217(1):195-209. doi: 10.1083/jcb.201704102. Epub 2017 Nov 13. PubMed
Small-Molecule Ferroptotic Agents with Potential to Selectively Target Cancer Stem Cells. Taylor WR, Fedorka SR, Gad I, Shah R, Alqahtani HD, Koranne R, Kuganesan N, Dlamini S, Rogers T, Al-Hamashi A, Kholodovych V, Barudi Y, Junk D, Rashid MS, Jackson MW, Tillekeratne LMV. Sci Rep. 2019 Apr 11;9(1):5926. doi: 10.1038/s41598-019-42251-5. PubMed
Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, Chen ZN, Jiang X. Nature. 2019 Aug;572(7769):402-406. doi: 10.1038/s41586-019-1426-6. Epub 2019 Jul 24. PubMed
p190A RhoGAP induces CDH1 expression and cooperates with E-cadherin to activate LATS kinases and suppress tumor cell growth. Ouyang H, Luong P, Frodin M, Hansen SH. Oncogene. 2020 Aug;39(33):5570-5587. doi: 10.1038/s41388-020-1385-2. Epub 2020 Jul 8. PubMed

If you have published an article using this material, please email us at to have your article added to this page.